ProMIS Neurosciences, Inc.
PMN
$0.52
$0.0193.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 10.64M | 8.54M | 7.12M | 6.50M | 7.88M |
| Gross Profit | -10.64M | -8.54M | -7.12M | -6.50M | -7.88M |
| SG&A Expenses | 2.69M | 6.16M | 5.67M | 6.47M | 6.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.33M | 14.70M | 12.78M | 12.97M | 14.26M |
| Operating Income | -13.33M | -14.70M | -12.78M | -12.97M | -14.26M |
| Income Before Tax | 2.78M | -563.40K | -12.20M | -11.89M | -13.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2.78 | -0.56 | -12.20 | -11.89 | -13.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.78M | -563.40K | -12.20M | -11.89M | -13.21M |
| EBIT | -13.33M | -14.70M | -12.78M | -12.97M | -14.26M |
| EBITDA | -13.31M | -14.67M | -12.75M | -12.94M | -14.24M |
| EPS Basic | -0.02 | -0.19 | -0.69 | -0.83 | -1.22 |
| Normalized Basic EPS | 0.05 | -0.12 | -0.43 | -0.52 | -0.76 |
| EPS Diluted | -0.02 | -0.19 | -0.69 | -0.83 | -1.22 |
| Normalized Diluted EPS | 0.05 | -0.12 | -0.43 | -0.52 | -0.76 |
| Average Basic Shares Outstanding | 104.15M | 88.91M | 71.26M | 60.07M | 49.12M |
| Average Diluted Shares Outstanding | 104.19M | 88.96M | 71.26M | 60.07M | 49.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |